Biodiversity Loss Hurts Drug Discovery, Says Medical Book
A new generation of drugs made from nature, from antibiotics to treatments for cancer, may be lost unless the world acts to stop biodiversity loss, according to a new book. These developments could come from chemicals made by frogs, bears and pine trees, but the authors of "Sustaining Life" warned that species loss from climate change and pollution would hit the future of medicine and the pharmaceutical industry.